General Information of Drug (ID: DMDG36X)

Drug Name
ABBV-155
Synonyms Mirzotamab clezutoclax
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Drug Type
Antibody drug conjugate
Cross-matching ID
TTD ID
DDE82F

References

1 ClinicalTrials.gov (NCT03595059) A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors. U.S. National Institutes of Health.